Geri
AKADEMİK

(Liste, ünvan ve isme göre alfabetik olarak sıralanmıştır.)

Kurum İçi Görevlendirme

text
Adı Soyadı Prof.Dr. Şeref DEMİRAYAK
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Ankara Üniversitesi 1979 Anadolu Üniversitesi Sağlık Bilimleri Enstitüsü

Daha Önce Görev Yaptığı Yerler

Anadolu Üniversitesi Eczacılık Fakültesi

Araştırma Alanları

Farmasötik ve Medisinal Kimya, İlaç Araştırma ve Geliştirme Çalışmaları, Heterosiklik Sentez, Organik Yapı Analizi, Fiziksel Organik Kimya, Yapı - Aktivite ilişkileri

Seçili Yayınları / Tüm Yayınları

Yurttaş, L., Demirayak, Ş., Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives, J. Enzyme Inhib. Med. Chem., 29(6) 811-822 (2014)

Yurttaş, L., Demirayak, Ş., Ilgın, S., Atlı, Ö., In vitro antitumor activity evaluation of some 1,2,4-triazine derivatives bearing piperazine amide moiety against breast cancer cells, Bioorg. Med. Chem., 22, 6313-6323 (2014).

Gundogdu-Karaburun, N., Karaburun, A. C., Demirayak, S., Kayagil, I., Yurttas, L., Synthesis and Anticancer Activity of Some 2-[3/4-(2-Substituted Phenyl-2- oxoethoxy)-benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one Derivatives, Letters in Drug Design & Discovery, 11(5), 578-585, 2014.

Tay, F., Duran, M., Demirayak, Ş., A quantum chemical DFT/HF study on acidity constant of some benzothiazole and thiazole derivatives, Indian J. Chem, 53B, 102-110 (2014).

Yurttaş, L., Duran, M., Demirayak, Ş., Karaca Gencer, H., Tunalı, Y., Synthesis and Initial Biological Evaluation of Substituted 1-Phenylamino-2-thio-4,5-dimethyl-1H-imidazole derivatives, Bioorg. Med. Chem. Lett., 23, 6764-6768 (2013).

Yurttaş, L., Demirayak, Ş., Çiftçi, G.A., Ulusoylar Yıldırım, Ş., Kaplancklı, Z.A., Synthesis and Biological Evaluation of Some 1,2-Disubstituted Benzimidazole Derivatives as New Potential Anticancer Agents, Arch. Pharm. Chem. Life Sci., 346, 403-414 (2013).

Duran, M., Demirayak, Ş., Synthesis of 2-[4,5-dimethyl-1-(phenylamino)-1H-imidazol-3 2-ylthio]-N-(thiazole-2-yl)acetamide derivatives and their anticancer activities, Med. Chem. Res., 22, 4110-2124 (2013).

Tay, F., Yurttas, L., Demirayak, Ş., Synthesis of some N-[4-(benzothiazole-2yl)phenyl]-2-aryloxyacetamide derivatives and their anticancer activities, J. Enzyme Inhib. Med. Chem., 27, 515-520 (2012).

Demirayak, Ş., Kayagil, I., Yurttas, L., Microwave supported synthesis of some novel 1,3-Diarylpyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities, Eur. J. Med. Chem., 46, 411-416, (2011).

Demirayak, Ş., Kayagil, I., Yurttas, L., Aslan, R., Synthesis of some imidazolyl-thioacetylpyrazolinone derivatives and their antinociceptive and anticancer activities, J. Enzim. Inh. Med. Chem., 25, 74-79 (2010).

Kayagil, I., Demirayak, Ş., Synthesis and anticancer activities of some thiazole derivatives, Phosphorus, Sulfur, Silicon and Related Elements, 184, 2197-2207 (2009).

Demirayak, Ş, Ali, F.D., Osman, B.S., Tunalı, Y., Some 6-Substituted 3-aryl-7-oxothiazolo[4,5-d]pyrimidin-2(3H)-thione derivatives and their antimicrobial activities, Phosphorus, Sulfur, Silicon and Related Elements, 182, 1793-1803 (2007).

Demirayak, Ş., Kayagil, İ., Synthesis of some 6,8-diarylimidazo[1,2-a]pyrazine derivatives by using either reflux or microwave irradiation method and investigation their anticancer activities, J. Heterocycl. Chem., 42, 319-325 (2005)

text
Adı Soyadı Prof.Dr. Mesut YILMAZ
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

Seçili Yayınları / Tüm Yayınları

text
Adı Soyadı Prof.Dr. Barkın BERK
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Eczacılık Fakültesi 1996 Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü, Farmasötik Kimya ABD

Daha Önce Görev Yaptığı Yerler

Hacettepe Üniversitesi, Eczacılık Fakültesi (1996-2003), Yeditepe Üniversitesi, Eczacılık Fakültesi (2003-2012), NIH/NIDDK, ABD (2009-2010), Yeditepe Sağlık Hizmetleri A.Ş. (2011-2012)

Araştırma Alanları

İlaç ArGe, Moleküler Modelleme, GPCR, Method Geliştirme ve Validasyon

Seçili Yayınları / Tüm Yayınları

- N. Uskent, S. Ayla, N. M. Mandel, M. Ozkan, M. Teomete, H. Baloglu, C. Aydincer, H. Yergok, E. Dogan, B. Berk, A. Yazar, Prognostic Significance Of Tumor Tissue Neugcgm3 Ganglioside Expression İn Patients Receiving Racotumomab Immunotherapy, Journal Of Oncology, 2020, Article id:1360431,
(2020).

- S. Demirayak, Z. Sahin, M. Ertas, E. F. Bulbul, C. Bender, S. N. Biltekin, B. Berk, B. N. Sağlık, S. Levent, L. Yurttas, Novel Thiazole-Piperazine Derivatives As Potential Cholinesterase İnhibitors, Journal Of Heterocyclıc Chemıstry, 56, 3370– 3386 (2019).

- M. Ertas, Z. Sahin, E. F. Bulbul, C. Bender, S. N. Biltekin, B. Berk, L. Yurttas, A. M. Nalbur, H. Celik, S. Demirayak, Potent Ribonucleotide Reductase İnhibitors: Thiazole-Containing Thiosemicarbazone Derivatives, Archiv Der Pharmazie, 352 (11), e1900033 (2019).

- H. Akgün, B. Kaya, Y. Mulazim, B. Keşanli, H. Sipahi, S. B. Kadioğlu Yaman, B. Berk, S. N. Biltekin, Synthesis And Biological Activity Studies Of Substituted N-(1,3-Dioxohexahydro-2H-İsoindol-2-yl) Benzenesulfonamide Derivatives, The Pharmaceutical And Chemical Journal, 6(2), 91-102 (2019).

-A. Şimşek, N. Taner, C. Macit, B. Berk, G. Mercanoğlu; The Importance of Computerized Drug Interaction Checker Programs Used in Community Pharmacies to Avoid Potential Drug Interactions: A Preliminary Study with Clarithromycin, İstanbul Medical Journal, 20 (1), 65-71 (2019).

-B. Giray, L. Yurttaş, Z. Şahin, B. Berk, Ş. Demirayak; Antimicrobial Evaluation Of Trisubstituted 2-Piperazinyl Thiazoles, Acta Pharm. Sci., 57 (1), 103-108 (2019).

- Z. Sahin, M. Ertas, C. Bender, E. F. Bülbül, B. Berk, S. N. Biltekin, L. Yurttas, S. Demirayak; Thiazole-Substituted Benzoylpiperazine Derivatives As Acetylcholinesterase İnhibitors, Drug Development Research, 79 (8), 406-425 (2018).

-Z. Şahin, M. Ertaş, B. Berk, S. N. Biltekin, L. Yurttaş, Ş. Demirayak; Studies on Non-Steroidal Structured Aromatase Enzyme Inhibitors; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole Derivatives, Bioorganic & Medicinal Chemistry, 26, 1986–1995 (2018).

- M. Ertaş, Z. Şahin, B. Berk, L. Yurttaş, S. N. Biltekin, Ş. Demirayak; Pyridine-Substituted Thiazolylphenol Derivatives; Synthesis, Modeling Studies, Aromatase İnhibition And Antiproliferative Activity Evaluation, Archive der Pharmazie, 351 (3-4), 1-11, (2018).

-N. Taner, B. N. Çattık, B. Berk; A Contraindication to Metformin Therapy: Renal Impairment - Adherence to Prescribing Guidelines at a Hospital in Turkey, Acta Pharm. Sci., 56 (63-70), 17-28 (2018).

- N. Uskent, N. M. Mandel, Z. Gülbaş, G. Baloğlu, B. Berk, R. Uslu, A. Yazar, H. Baloğlu; Cytolytic Tests With Hyperimmune Patient Sera Is A Good Prognostic Tool In Racotumomab Immunotherapy In Advanced Non-Small Cell, Advances in Modern Oncology Research, 3(5), 223-231 (2017)

.-B. Berk, Y. Altas Tahirovic, E. F Bülbül, S. N. Biltekin; The Synthesis, Antimicrobial Activity Studies, and Molecular Property Predictions of Novel Benzothiazole-2-Thione Derivatives, Acta Pharm. Sci., 55 (3), 17-28 (2017).

- B. Berk, Z. Şahin; Molecular Modelling and Activity Analysis of Mycobacterium tuberculosis DNA Gyrase B ATPase Active Site, Acta Pharm. Sci., 55(1), 7-19 (2017).

- B. Berk, M. Ertaş, S. N. Biltekin; Synthesis, Antimicrobial Activity Studies and Molecular Property Predictions of Schiff Bases Derived from ortho-Vanillin, Acta Pharm. Sci., 55(1), 83-96 (2017).

- B. Berk, G. Kaynar, M. Ertaş, S. N. Biltekin; Molecular Modelling and Compound Activity of The Escherichia Coli and Staphylococcus Aureus DNA Gyrase B ATPase Site, Acta Pharm. Sci., 55(1), 97-117 (2017).

- B. Berk, C. Bender, E. Küpeli Akkol, E. Yeşilada; Design and Synthesis of Stable N-[2-(aryl/heteroaryl substituted)ethyl] propanamide Derivatives of (S)-Ketoprofen and (S)-Ibuprofen as Non-Ulcerogenic Anti-Inflammatory and Analgesic Agents, Acta Pharm. Sci., 54(1), 65-80 (2016).
- E. Karataş-Koçberber, C. Ceylan, D. Kızılaslan, C. Erdoğan, B. Berk; The evaluation of phenytoin treatment according to the corrected phenytoin levels, International Journal Of Clinical Pharmacy, 38(5), 1340-1341 (2016).

- C. Ceylan, E. Karataş Koçberber, N. Taner, B. Berk; The Determine of Possible Drug Interaction of Clarithromycin, International Journal Of Clinical Pharmacy, 38(5), 1341 (2016).

- E. Karataş-Koçberber, N. Abunahlah, B. Berk; Prescribing pattern of PPI and clopidogrel in community pharmacies in Turkey, International Journal Of Clinical Pharmacy, 38(2), 504-505 (2016).

- F.E. Onen-Bayram, K. Buran, I. Durmaz, B. Berk, R. Cetin-Atalay; 3-Propionyl-thiazolidine-4-carboxylic Acid Ethyl Esters: A Family Of Antiproliferative Thiazolidines, MedChemComm, 6(1), 90-93 (2015).

- H. Akgün, I. Karamelekoğlu, B. Berk, I. Kurnaz, G. Sarıbıyık, S. Oktem, T. Kocagöz; Synthesis And Antimycobacterial Activity Of Some Phthalimide Derivatives, Bioorganic and Medicinal Chemistry, 20(13), 4149-54 (2012).

- S. Vilar, J. Karpiak, B. Berk, S. Costanzi; In Silico Analysis Of The Binding Of Agonists And Blockers To The ß2-Adrenergic Receptor, Journal of Molecular Graphics and Modeling, 29(6), 809-817 (2011).

- B. Berk, D. Us, S. Öktem, T. Kocagöz, B. Çağlayan, I. A. Kurnaz, D. D. Erol; Molecular Modeling And Antimycobacterial Studies Of Mannich Bases: 5-Hydroxy-2-Methyl-4H-Pyran-4-Ones, Turkish Journal of Chemistry, 35(2), 317-330 (2011).

- S. Vilar, G. Ferino, S. S. Phatak, B. Berk, C. N. Cavasotto, S. Costanzi; Docking-Based Virtual Screening For Ligands Of G Protein-Coupled Receptors: Not Only Crystal Structures But Also İn Silico Models, Journal of Molecular Graphics and Modeling, 29(5), 614-623 (2011).

- D. Us, B. Berk, E. Gürdal, N. Aytekin, T. Kocagöz, B. Çağlayan, I. A. Kurnaz, D. D. Erol; Mannich Base Derivatives Of 3-Hydroxy-6-Methyl-4H-Pyran-4-One With Antimicrobial Activity, Turkish Journal of Chemistry, 34, 447-456 (2010).

- H. Maruoka, M. O. Barrett, H. Ko, D. K. Tosh, A. Melman, L. E. Burianek, R. Balasubramanian, B. Berk, S. Costanzi, T. K. Harden, K. A. Jacobson; Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5'-Triphosphate ?-Ester Modifications, Journal of Medicinal Chemistry, 53 (11), 4488-4501 (2010).

- D. Us, E. Gürdal, B. Berk, S. Öktem, T. Kocagöz, B. Çağlayan, I. A. Kurnaz, D. D. Erol; 4H-Pyran-4-one Derivatives; Leading Molecule For Preparation Of Compounds with Antimycobacterial Potential, Turkish Journal of Chemistry, 33, 803-812 (2009).

- H. Akgün, B. Berk, D. Demir Erol, G. Mercanoğlu, Ö. F. Bayrak , B. Çağlayan, A. Dedeağaç, I. A. Kurnaz; Nitric Oxide Releasing Derivatives of [(2-chloroethyl)ureido]benzoic Acid Esters As Potential Antineoplastic Agents, Turkish Journal of Chemistry, 33, 107-121 (2009).

- B. Berk, D. D. Erol, E. Kupeli, E. Yesilada; Design and Synthesis of Some (S)-2-(6-methoxy naphthalen-2-yl)-N-substituted-ethylpropanamide Derivatives as Potent Non-ulcerogenic Anti-inflammatory and Analgesic Agents, ArzneimForsch/DrugRes, 59(4), 195-201 (2009).

text
Adı Soyadı Prof.Dr. Gülden Zehra OMURTAG
E-Posta [email protected]
Detay Öz Geçmiş
Medya

İstanbul İktisadi Ticari İlimler Akademisi 1981 İstanbul Üniversitesi, Sağlık Bilimleri Enstitüsü

Daha Önce Görev Yaptığı Yerler

İstanbul Üniversitesi, Veteriner Fakültesi(1984-1992) ve Marmara Üniversitesi Eczacılık Fakültesi (1992-2015)

Araştırma Alanları

İlaç Araştırmaları, Genetik Toksikoloji, Besin Toksikolojisi, Çevre Toksikolojisi

Seçili Yayınları / Tüm Yayınları

1.YEŞİLALTAY, A. K., ERSOY, Ö., OMURTAG, G. Z. and YURDUN, T., "Effects of Carbamazepine on Hepatic Glutathione Level in Rats and Determination of Carbamazepine and its Epoxide Metabolite in Plasma by HPLC", Drug Metab. Drug Interact., 14(4), 251-258, (1998).

2.OMURTAG, G.Z., and YAZICIOĞLU, D., "Determination of T-2 Toxin in Grain and Grain Products by HPLC and TLC", J. Environ. Sci. Health, Part B, 35(6), 797-807, (2000).

3.OMURTAG, G.Z., "Determination of Fumonisin B1 and B2 in Corn and Corn-Based Products by High-Performance Liquid Chromatography", J. Food Prot., 64(7), 1072-1075, (2001).

4.OMURTAG, G.Z., and YAZICIOĞLU, D., "Occurence of T-2 Toxin in Processed Cereals and Pulses in Turkey Determined by HPLC and TLC", Food Addit. Contam., 18(9), 844-849, (2001).

5.YURDUN, T., OMURTAG, G.Z., and ERSOY, Ö., "Incidence of Patulin in Apple Juices Marketed in Turkey", J. Food Prot., 64(11), 1851-1853, (2001).

6.OMURTAG, G.Z., and BEYOĞLU, D., "Occurence of Deoxynivalenol (Vomitoxin) in Processed Cereals and Pulses in Turkey ", Food Addit. Contam., 20(4), 405-409, (2003).

7.OMURTAG, G.Z., ve YAZICIOĞLU, D., "Determination of Fumonisin B1 and B2 in Herbal Tea and Medicinal Plants in Turkey by High-Performance Liquid Chromatography", J. Food Prot., 67(8), 1782-1786, (2004).

8.OMURTAG, G.Z., GÜRANLIOĞLU, F. D., ŞEHİRLİ, Ö., ARBAK, S., USLU, B., GEDİK, N., and ŞENER, G., “Protective Effect of Aqueous Garlic Extract Against Naphthalene-Induced Oxidative Stress in Mice”, J. Pharm. Pharmacol., 57(5), 623-630, (2005).

9.ŞENER, G., OMURTAG, G.Z., ŞEHİRLİ, Ö., TOZAN, A., YÜKSEL, M., ERCAN, F., and GEDİK, N., “Protective Effects of Ginkgo Biloba Against Acetaminophen-Induced Toxicity In Mice”, Mol. Cell. Biochem., Feb.; 283(1-2), 39-45, (2006).

10.OMURTAG, G.Z., and BEYOĞLU, D., "Occurence of Deoxynivalenol (Vomitoxin) in Beer in Turkey Detected by HPLC”, Food Control, Feb.; 18(2), 163-166, (2007).

11.TOZAN, A., ŞEHİRLİ, Ö., OMURTAG, G.Z., ÇETİNEL, Ş., CONTUK, G., GEDİK, N. and ŞENER, G., “Ginkgo biloba extract reduces napthalene-induced oxidative damage in mice”, Phytotherapy Research, 21, 72-77, (2007).

12.OMURTAG, G.Z., TOZAN, A., SİRKECİOĞLU, O., KUMBARACI V., and ROLLAS, S. “Occurrence of Diacetoxyscirpenol (Anguidine) in Processed Cereals and Pulses in Turkey by HPLC”, Food Control, 18(8), 970-974, (2007).

13.ŞENER, G., SEHIRLI, Ö., TOZAN, A., VELIOĞLU-ÖVUNÇ, A., GEDIK, N., and OMURTAG, G.Z., “Ginkgo biloba Extract Protects Against Mercury (II)-Induced Oxidative Tissue Damage in Rats”, Food and Chemical Toxicology, 45(4): 543-550, (2007).

14.GÜL, H., OMURTAG, G., ÖNAL, A.E., CLARK, P.M., TOZAN, A., and ÖZEL, S. “Nonprescription medication purchases and the role of pharmacists as health care workers on self-medication in Istanbul”, Medical Science Monitor, 13(7), PH9-14, (2007).

15.BEYOĞLU, D., and OMURTAG, G.Z., “Occurrence of Naphthalene In Honey In Turkey By HPLC“, J. Food Prot., 70(7), 1735-1738, (2007).

16.SEHIRLI, Ö., TOZAN, A., OMURTAG, G.Z., KESKİNEL, Ş., CONTUK, G., GEDİK, N., and ŞENER, G. ” Protective Effect of Resveratrol Against Naphthalene-Induced Oxidative Stress in Mice”, Ecotoxicol Environ Saf, 71(1), 301-308, (2008).

17.OMURTAG, G.Z., TOZAN, A., SEHIRLI, A.Ö., and ŞENER, G. ” Melatonin protects against endosulfan-induced oxidative tissue damage in rats”, Journal of Pineal Research, 44(4), 432-438, (2008).

18.YAZAR, S., and OMURTAG, G. Z., "Fumonisins, trichothecenes and zearalenone in cereals ", Int. J. Mol. Sci., 9(11), 2062-2090, (2008).
19.GENCOGLU, N., SENER, G., OMURTAG, G.Z., TOZAN, A., USLU, B., ARBAK, S., and, HELVACIOGLU; D. ”Comparision of biocompatibility and cytotoxicity of two new root canal sealers” , Acta Histochem, 112(6), 567-575, (2010).

20.BEYOĞLU, D., OZKOZACI T., AKICI N, OMURTAG GZ, AKICI A., CERAN O. and SARDAS S. "Assessment of DNA damage in children exposed to indoor tobacco smoke" , Int J Hyg Environ Health, 213, 40-43, (2010).

21.SARDAS. S., OMURTAG GZ, TOZAN A, GÜL H, BEYOĞLU D. Evaluation of DNA damage in construction site workers occupationally exposed to welding fumes and solvent based patients in Turkey. Toxicol Ind Health. 26(9), 601-608, (2010).

22.ALTURFAN A.A., TOZAN- BECEREN A, SEHIRLI, A.Ö.,DEMİRALP E., ŞENER, G., OMURTAG, G.Z. "Resveratrol Ameliorates Oxidative DNA Damage and Protects Against Acrylamide-Induced Oxidative Stress In Rats", Molecular Biology Reports, 39(4), 4589-4596, (2012).

23.SARDAS, S, OMURTAG, G.Z., MONTEIRO, I.F.C., TOPSAKAL, N., BEYOGLU, D., TOZAN_BECEREN, A., COTUK, H.B., "Assessment of DNA Damage and Protective Role of Vitamin E Supplements After Exhaustive Exercise By Comet Assay In Athletes" Journal of Clinical Toxicology, (2012).

24.ALTURFAN E.I., TOZAN- BECEREN A, SEHIRLI, A.Ö.,DEMİRALP E., ŞENER, G., OMURTAG, G.Z. "Protective Effect Of N-Acetyl-L-Cysteine Against Acrylamide-Induced Oxidative Stress In Rats", Turkish Journal of Veterinary And Animal Sciences, 36(4): 438-445, (2012).

25.GURER SOYOGUL U., OMURTAG KORKMAZ I., ULUSOYLU DUMLU M., OMURTAG, G.Z. "Occurence Fumonisin B1 and Fumonisin B2 in homemade medicinal plants: exposure assessment in northern Turkey. Acta Alimentaria, Vol. 45 (1), 54–60, (2016).

26.AYDEMIR S, AKGUN S.G., BECEREN A., YUKSEL M., KUMAS M., ERDOGAN N., SARDAS S.,OMURTAG G.Z. “Melatonin Ameliorates Oxidative DNA Damage And Protects Against Formaldehyde-Induced Oxidative Stress In Rats”. Int J Clin Exp Med, 10(4): 6250-6261, (2017).

27.BECEREN A., ŞEHİRLİ A.Ö., ARBAK S., TURAN P., ŞENER G., “Protective Effect of N-Acetyl-L-Cysteine (NAC) on Endusulfan-Induced Liver and Kidney Toxicity in Rats”. Int J Clin Exp Med, 10(7): 10031-10039 (2017).

28.PEKEL A.Y., ÇALIK A., ALATAŞ M.S., KUTER E., CENGİZ Ö., OMURTAG G.Z., İNAN G., “Evaluation of Correlations Between Nutrients, Fatty Acids, Heavy Metals, and Deoxynivalenol in Corn (Zea mays L.)”. The Journal of Applied Poultry Research, (2018) .

29. YESIL DEVECIOGLU T., AYDOĞAN F., OMURTAG G.Z., SENEL BESE N., SARDAS. S., “Anastrozol Kullanan Meme Kanserli Hastalarda Genotoksisite Riski ve DNA Onarim Kapasitelerinin Arastirilmasi - Investigation of Genotoxicity Risk and DNA Repair Capacity in Breast Cancer Patients Using Anastrozole”. Northern Clinics of Istanbul, 5(1): 6-13 (2018).
30.BECEREN A., AKDEMİR, N., TATLIPINAR, E., OMURTAG, G.Z., ŞARDAŞ, S., “DNA Damage in Gasoline Station Workers Caused by Occupational Exposure to Petrol Vapour in Turkey“, Acta Pharm. Sci., 54(1), 53-62, (2016).

31.BECEREN A., SARIKAYA, B., OMURTAG, G.Z., TATLIPINAR, E., ŞARDAŞ, S., "Antioksidan Maddelerin Mutajenite Üzerine Etkilerinin Ames Testi ile İncelenmesi". Marmara Pharmaceutical Journal, 21(3), 455-460, (2017).

32.VURAL H.A., OMURTAG G.Z., ALTINER A:, BARAN A., “Reproductive Toxicity of Soy and Soy-Based Products”, Advances in Clinical Toxicology, 2(1): 000112, (2017).

33.TATLIPINAR, M.E., GÖKSU Y., OMURTAG, G.Z., “The Role of Pharmacists in Kırklareli (Turkey) as Primary Health Care Providers “, Acta Pharm. Sci., 55(2), 95-112, (2017).

34.KONAK, Ö., TATLIPINAR, M.E., OMURTAG, G.Z., “Evaluation of Knowledge Level About Asbestos Exposure in Urban Transformation Construction Areas”, Acta Pharm. Sci., 55(4), 85-100, (2017).

35.BECEREN A., ŞEHİRLİ A.Ö., ARBAK S., TURAN P., ŞENER G., “Protective Effect of N-Acetyl- L-Cysteine (NAC) on Endusulfan-Induced Liver and Kidney Toxicity in Rats”. IJCEM, 2017

36.ÖZDATLI Ş., KAŞIKÇIOĞLU G., GÖÇMEN E., OMURTAG G.Z. “A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment”. Toxicology Letters, 258: 132-133, September 2016.

37.OMURTAG, G. Z., ÜLKER, N.S., “Buzdolabındaki Gıdalarda Bakteri Oluşumu”. Eczacı Farmakope, 2(9): 18-21, (2018).

text
Adı Soyadı Dr.Öğr.Üye. Pakize YİĞİT
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Yıldız Teknik Üniversitesi 2007 İstanbul Üniversitesi Sayısal Yöntemler BD

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

istatistik, veri madenciliği

Seçili Yayınları / Tüm Yayınları

text
Adı Soyadı Dr.Öğr.Üye. Tuğba İDUĞ
E-Posta [email protected]
Detay Öz Geçmiş
Medya

İnönü Üniversitesi 2011 İstanbul Üniversitesi

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

Fitokimya, Tıbbi bitkiler, Doğal kaynaklı bileşiklerin izolasyonu

Seçili Yayınları / Tüm Yayınları

text
Adı Soyadı Dr.Öğr.Üye. Deniz DURALI
E-Posta [email protected]
Detay Öz Geçmiş
Medya

1995 İmmünoloji/Université Paris Descartes

Daha Önce Görev Yaptığı Yerler

INSERM (Institut national de la santé et de la recherche médicale / Fransa) DETAE (İstanbul Üniversitesi Deneysel Tıp Araştırma Enstitüsü / Türkiye) TÜBİTAK-MAM (Türkiye Bilimsel ve Teknolojik Araştırma Kurumu - Marmara Araştırma Merkezi / Türkiye) İstanbul Medipol Üniversitesi (Türkiye)

Araştırma Alanları

İmmün regülasyon İmmün hafıza Hücresel immünite Anti-viral immünite İnflamasyon Aşı

Seçili Yayınları / Tüm Yayınları

de Goër de Herve MG, Abdoh M, Jaafoura S, Durali D, Taoufik Y. Follicular CD4 T Cells Tutor CD8 Early Memory Precursors: An Initiatory Journey to the Frontier of B Cell Territory. iScience. 2019 Sep 14;20:100-109. doi: 10.1016/j.isci.2019.09.012.

Durali D., de Goer de Herve MG., Gasnault J., Taoufik Y. : B cells and progressive multifocal leukoencephalopathy: search for the missing link. Front. Immunol. 6 (241) : 1-9, 2015

de Goër de Herve MG, Durali D, Dembele B, Giuliani M, Tran TA, Azzarone B, Eid P, Tardieu M, Delfraissy JF, Taoufik Y. Interferon-alpha triggers B cell effector 1 (Be1) commitment. PLoS One. 2011 Apr 29;6(4):e19366.

de Goer de Herve MG, Durali D, Tran TA, Maigne G, Simonetta F, Leclerc P, Delfraissy JF, Taoufik Y. Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40. Blood. 2005 Oct 15;106(8):2806-14.

Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood. 2003 Dec 1;102(12):4084-9.

Gasnault J, Kahraman M, de Goer de Herve MG, Durali D, Delfraissy JF, Taoufik Y. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS. 2003 Jul 4;17(10):1443-9

Durali D, Morvan J, Letourneur F, Schmitt D, Guegan N, Dalod M, Saragosti S, Sicard D, Levy JP, Gomard E. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J Virol. 1998 May;72(5):3547-53.

text
Adı Soyadı Dr.Öğr.Üye. Çağlar MACİT
E-Posta [email protected]
Detay Öz Geçmiş
Medya

Yeditepe Üniversitesi 2007 Marmara Üniversitesi SBE. Farmakoloji

Daha Önce Görev Yaptığı Yerler

Yeditepe Üniversitesi Eczacılık Fakültesi

Araştırma Alanları

1. Kardiyovasküler sistem 2. Antioksidan sistem 3. antibiyotikler

Seçili Yayınları / Tüm Yayınları

Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)

Çevik, Ö, Oba, R., Macit, Ç., Çetinel, Ş., Çlingir, Ö. T., Şener, E., Şener, G. Lycopene inhibits caspase-3 activity and reduces oxidative organ damage in a rat model of thermal injury. Burns. 2012; 38: 861-871.

Reis, R., Charehsaz, M., Sipahi, H., Ekici, A. I. D., Macit, Ç., Akkaya, H. and Aydın, A. (2017), Energy Drink Induced Lipid Peroxidation and Oxidative Damage in Rat Liver and Brain When Used Alone or Combined with Alcohol. Journal of Food Science, 82: 1037–1043.

Macit C, Clark PM, Taner N, Bingol C, Mercanoglu G, Yuksel G. A survey on awareness, knowledge, and attitudes toward epilepsy in an urban community in Turkey. Niger J Clin Pract 2018;21:979-87.

Uluslararası diğer hakemli dergilerde yayınlanan makaleler

Macit C, Mercanoglu G, Safran N, Gungor M, Eroglu L. Time to onset of anxiety-and depression-like behaviours in rats after myocardial infarction and association with autonomic control of heart. Neuroanatomy. 2009; 8: 20-25.

F. Cevik, M. Celik, P.M. Clark, C. Macit. Sedation and Analgesia in Intensive Care: A Comparison of Fentanyl and Remifentanil. Pain Research and Treatment, 2011, DOI: 10.1155/2011/650320.

Mercanoglu G, Macit C, Mercanoglu F. Stress as a Risk Factor for Cardiovascular Events. Cardiol Pharmacol, 2015; 4:2, DOI: 10,4172/2329-6607.1000140.

Kadioglu B, Erciyes M, Kocsar S, Kaspar C, Erguven M, Macit C, Clark PM. The Effect of Pharmacist-Led Education on the Quality of Life of Children with Familial Mediterranean Fever. Pharm Pharmacol Int J, 2015; 2(3):00020.

Macit C, Mercanoglu G, Mercanoglu F. A Direct Renin İnhibitor Aliskiren: Re-Evaluation of Effectiveness. J Drug Metab Toxicol, 2015; 6(3): 1000185.

Gunes SS, Macit C, Mercanoglu G, Taner N, Clark PM. A cross-sectional study from Turkey: The impact of community pharmacist let educational intervention on adherence to antibiotic therapy. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences (RRJPPS), 2016; 5(3): 29-37.

Macit C, Taner N, Mercanoglu G, Mercanoglu F. Brand Loyalty as a Strategy for the Competition with Generic Drugs: Physicians Perspective. J Dev Drugs, 2016; 5: 159. doi:10.4172/2329-6631.1000159

Macit C, Taner N, Ozbay L., Behzetoglu Y, Mercanoglu G. Clinical Impacts of Cyp3a4 Isoenzyme on Drugs Used in Treatment of Cardiovascular Diseases: Drug-Drug Interactions. Cardiol Cardiovascmed 2016; 1 (1): 43-49

Macit C., Tatlipinar ME., Caglar ES., Taner N., Turgut S., Sarikaya EG. Comparison of 3 oses of Aloe vera and Burn Drugs in Market on Burnt Rat Models. Acta Pharm. Sci, 2018;56(2):93-101.DOI: 10.23893/1307-2080.APS.05614

Ulusal hakemli dergilerde yayınlanan makaleler

Philip Martin Clark, Caglar Macit, Sule Apikoglu-Rabus, Sude Cetin, Hüseyin Hilmi Sabuncu. An Assessment of the Perceived Effectiveness and Safety of Influenza Vaccine. Hacettepe University Journal of the Faculty of Pharmacy, 2011; 31(2): 119-136.

Nefise Bilge Göktay, Suna Telefoncu, S.Beril Kadıoğlu, Çağlar Macit, Nazlı Şencan, Philip Martin Clark. The role of the patient education in adherence to antibiotic therapy in primary care. Marmara Pharmaceutical Journal, 2013; 17: 1-7.

Beril G. Kivrak-Bernardelli, Caglar Macit, S. Beril Kadioglu, Taflan Salepci, Philip M. Clark. Quality of life assessment of patients with metastatic lung cancer receiving Platinium-based chemotherapy. Marmara Pharmaceutical Journal, 2013; 17: 120-130.

Güldem Mercanoğlu, Semen Yeşil Önder, Çağlar Macit, Fehmi Mercanoğlu. The effect of nebivolol on acute renal injury developed after myocardial ischemia: A preclinical study. Med Bull Haseki, 2018; 56:228-34.

Şimşek A, Macit Ç, Taner N, Berk B, Mercanoğlu G. The Importance of Computerized Drug Interaction Checker Programs to Avoid Potential Drug-Drug Interactions used in Community Pharmacies: A Preliminary Study with Clarithromycin. İstanbul Med J 2019; 20(1): 67-71. DOI: 10.5152/imj.2018.45712

text
Adı Soyadı Dr.Öğr.Üye. Rashida Muhammad UMAR
E-Posta [email protected]
Detay Öz Geçmiş
Medya

HACETTEPE ÜNİVERSİTESİ 2011 MARMARA ÜNİVERSİTESİ

Daha Önce Görev Yaptığı Yerler

MARMARA ÜNİVERSİTESİ

Araştırma Alanları

KLİNİK ECZACILIK

Seçili Yayınları / Tüm Yayınları

text
Adı Soyadı Dr.Öğr.Üye. Neda TANER
E-Posta [email protected]
Detay Öz Geçmiş
Medya

istanbul medipol üniversitesi 2015 İstanbul Medipol Üniversitesi

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

klinik eczacılık- ilaç ilaç etkileşimleri- farmakoloji- kardiyovaskular

Seçili Yayınları / Tüm Yayınları

7. Yayınlar
7.1. Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)

Ceylan C, Karataş Koçberber E, Taner N, Berk B; The Determine of Possible Drug Interaction of
Clarithromycin, International Journal Of Clinical Pharmacy, 38(5), 1341 (2016).

Macit C, Clark PM, Taner N, Bingol C, Mercanoglu G, Yuksel G. A survey on awareness, knowledge,
and attitudes toward epilepsy in an urban community in Turkey. Niger J Clin Pract. 2018 Aug;21(8):979- 987. doi:10.4103/njcp.njcp_199_17. PubMed PMID: 30073998.






7.2. Uluslararası diğer hakemli dergilerde yayınlanan makaleler
Gunes SS, Macit C, Mercanoglu G, Taner N, Clark PM. A cross-sectional study from Turkey: The impact of community pharmacist let educational intervention on adherence to antibiotic therapy. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences (RRJPPS), 2016; 5(3): 29-37.

Macit C, Taner N, Mercanoglu G, Mercanoglu F. Brand Loyalty as a Strategy for the Competition with Generic Drugs: Physicians Perspective. J Dev Drugs, 2016; 5: 159. doi:10.4172/2329-6631.1000159


Macit C, Taner N, Ozbay L., Behzetoglu Y, Mercanoglu G. Clinical Impacts of Cyp3a4 Isoenzyme on Drugs Used in Treatment of Cardiovascular Diseases: Drug-Drug Interactions. Cardiol Cardiovascmed 2016; 1 (1): 43-49

Taner N, Çattık B, Berk B. A Contraindication to Metformin Therapy: Renal Impairment Adherence to Prescribing Guidelines at a Hospital in Turkey. Acta Pharm.Sci.56(1): 63-70, 2018.

Macit C., Tatlipinar ME., Caglar ES., Taner N., Turgut S., Sarikaya EG. Comparison of 3 oses of Aloe vera and Burn Drugs in Market on Burnt Rat Models. Acta Pharm. Sci, 2018;56(2):93-101.DOI: 10.23893/1307-2080.APS.05614



7.3. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler
Sözlü Sunumlar:

Taner N, Karatas Kocberber E, Ceylan C, Berk B. Evaluation Of Renal Function In Patients Using Metformin. 7th. European Congress of Pharmacology. June 26-30, 2016. Istanbul, Turkey.

Macit C, Taner N, Simsek A, Olguner Mercanoglu HG.Drug – Drug Interactions In Pediatric Patients Taking Clarithromycin.12th International Symposium On Pharmaceutical Science. June 26-29, 2018. Ankara, Turkey.

Poster Sunumları:

Taner N, Ceylan C. Farmasötik Bakımda Hasta Uyuncunun Önemi. 2nd. International Convention of Pharmaceuticals and Pharmacies (IVEK). November 27-29, 2015. Istanbul, Turkey.

Ceylan C, Karatas-Kocberber E, Taner N, Berk B. The Determine of Possible Drug Interaction of Clarithromycin. ESCP Workshop. June 10-11, 2016. Basel, Switzerland.

Behzetoglu Y., Taner N., Macit C., Ozbay L. Clinical Impacts of CYP3A4 Single Nucleotide Polymorphisms on Drug Metabolism. 7th Annual Iranian Clinical Pharmacy Congress. May 25-27, 2016. Tehran, Iran.

Taner N, Karatas Kocberber E, Ceylan C, Berk B. The Importance Of Monitoring Renal Function In Patient Using Metformin. 7th Annual Iranian Clinical Pharmacy Congress. May 25-27, 2016. Tehran, Iran.

Karatas Kocberber E, Taner N, Berk B. The Importance of Therapeutic Drug Monitoring in Patient Treated with Phenytoin. 7th Annual Iranian Clinical Pharmacy Congress. May 25-27, 2016. Tehran, Iran.

Ceylan C, Karatas Kocberber E, Taner N, Berk B. The Risk of Drug Interaction in Hospitalized Patients Using Clarithromycin. 7th. European Congress of Pharmacology. June 26-30, 2016. Istanbul, Turkey.

Karatas-Kocberber E, Mutlu M, Mancar B, Taner N, Cattık B.N, Berk B. The Risk of Drug Interaction And Polypharmacy In Geriatric Patients. 7th. European Congress of Pharmacology. June 26-30, 2016. Istanbul, Turkey.

E. Karatas Kocberber, N. Taner. ‘The Evaluation of Antibiotics Susceptibility and Antibiotic Therapy of Inpatients’ .45TH ESCP Symposium on Clinical Pharmacy, Oslo, Norveç, 2016.

Taner N, Berk B. Clinical pharmacy education and practice in turkey. 8th Annual Iranian Clinical Pharmacy Congress. May 24-26, 2017. Tehran, Iran.

Durmazpinar S, Taner N, Macit C. Assesment Of Breast Cancer Therapy In Hospital: A Restrospective Study. 12th International Symposium On Pharmaceutical Science. June 26-29, 2018. Ankara, Turkey.



7.4. Yazılan Uluslararası / Ulusal kitaplar veya kitaplarda bölümler

Taner N. The Liposomal Drug Delivery Systems Developed For Treatment Of COPD. LAP LAMBERT Academic Publishing. 2017.

7.5. Ulusal hakemli dergilerde yayınlanan makaleler

7.6. Ulusal bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler

Taner N, Berk B. Yoğun Bakım Hastalarında Enteral Parenteral Beslenmesinin Değerlendirilmesi.3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi. 9-12 şubat 2017. Antalya, Turkey.


7.7. Diğer yayınlar

8. Projeler

9. İdari Görevler
Istanbul Medipol Üniversitesi Eczacılık Fakültesi Akreditasyon Komisyonu Üyeliği (Nisan 2016- )
Istanbul Medipol Üniversitesi Eczacılık Fakültesi Sosyal Komite Üyeliği (Nisan 2016- )
Istanbul Medipol Üniversitesi Eczacılık Fakültesi 2017 Öz Değerlendirme Raporu Hazırlama Komisyonu 2017-2018
Istanbul Medipol Üniversitesi Eczacılık Fakültesi Eğitim Komisyonu Üyeliği ( Haziran 2018- )
Istanbul Medipol Üniversitesi Eczacılık Fakültesi Genişletilmiş Eğitim Programı (GEP) Komisyonu Üyesi (Hairan 2018- )
Acta Pharmaceutica Sciencia Language Editor ( 2018- )

10. Bilimsel ve Mesleki Kuruluşlara Üyelikler
İran Klinik Eczacılık Derneği (2016- )
Klinik Eczacılık Derneği (2016- )
İstanbul Eczacı Odası Rehber Eczanem programı (2017- )

Kurum Dışı Görevlendirme

Bilgi Talep Formu